Macrogenics Inc (NASDAQ:MGNX) currently has a daily average trading volume of 581.04K but it saw 829386 shares traded in last market. With a market cap of 193.31M USD, the company’s current market price of $3.08 came rising about 2.67 while comparing to the previous closing price of $3.00. In past 52 weeks, the stock remained buoying in the range of price level as high as $21.88 and as low as $2.91. In the recent trading on the day, stock has struck highest price mark of $3.01 while lowest mark touched by it was $3.12.
Taking a look at 20-day trading activity of Macrogenics Inc (MGNX) gives us an average price of $3.22, while its current price level is -85.92% below from 52-week high level whereas it is 5.84% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $3.41 while that of 200 days or SMA-200 reads an average of $5.38. A closer look into the stock’s movement over the week reveals that its volatility is standing at 5.34% during that period while stretching the period over a month that decreases to 5.18%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 42.09 which implies that the stock is in neutral territory.
Over the week, MGNX’s stock price is moving 1.32% up while it is -4.05% when we observe its performance for the past one month. Year-to-date it is -5.23% down and over the past year, the stock is showing a downside performance of -74.33%.
The company is expected to be releasing its next quarterly report in February, for which analysts forecasted an EPS of -0.66 while estimate for next year EPS is -1.49. In next quarter, company is expected to be making quarterly sales of $9.32M as analysts are expecting the sales for current fiscal year at $157.97M and seeing the company making $58.52M in sales next year. Moreover, analysts are in estimates of $30.93M for current-quarter revenue.
Currently, Macrogenics Inc’s total number of outstanding shares is 62.76M with 2.65% of that held by the insiders while 93.65% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -65.33% and return on equity (ROE) at -62.17%. Stock’s beta reads 2.01. Stock has a price to book (P/B) ratio of 1.61 while price to sale or P/S ratio amounts to 1.37. Its return on asset (ROA) is -32.30% on average.
